05/09/2024
3:46 PM | Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
3:48 PM | Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:49 PM | Moran Susan (Reporting)
Tyra Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
3:49 PM | Moran Susan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:08 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
11:15 PM | Tyra Biosciences (Filer)
| Form EFFECT | |
04/05/2024
3:20 PM | Tyra Biosciences (Filer)
| Form PRE 14A | |
|
03/19/2024
6:58 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:01 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | Tyra Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/19/2024
3:35 PM | Tyra Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
4:46 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
03/08/2024
4:38 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:40 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:58 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:00 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:24 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/09/2024
6:26 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13G/A | |
02/08/2024
4:10 PM | Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/08/2024
4:16 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:09 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:22 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:23 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
3:56 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024
3:40 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
| Form SC 13D/A | |
02/05/2024
5:05 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:04 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:47 PM | Harris Todd (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:24 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
8:00 AM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:16 PM | Tyra Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
3:50 PM | Tyra Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
6:27 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:36 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
6:37 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
4:30 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
4:34 PM | Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
4:38 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Crypto 9-5 Escape Plan (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
08/01/2023
4:41 PM | Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
7:52 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
6:35 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:41 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:31 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
7:31 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:30 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
2:42 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
7:16 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:42 PM | Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:33 PM | Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:37 PM | Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:25 PM | Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
7:58 PM | Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:00 PM | Harris Todd (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Simson Jake (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | CHEN ISAN (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
